Search all trials

Find therapies in clinical trials near you – page 30

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Study on Early vs. Late Epoetin Alfa Treatment for Adults with Low-Risk MDS and Anemia Not Requiring Blood Transfusions

Not recruiting

Registered drugNo placebo

Study on Early vs. Late Epoetin Alfa Treatment for Adults with Low-Risk MDS and Anemia Not Requiring Blood Transfusions

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Epoetin Alfa

Contact Research Centre

Chronic myelomonocytic leukaemia

Not recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of Azacitidine and Venetoclax for Patients with Higher-Risk Chronic Myelomonocytic Leukemia (CMML)

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Peripheral arterial occlusive disease

Not recruiting

Registered drug

Study of sildenafil to improve walking distance in patients with peripheral arterial disease and intermittent claudication

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Sildenafil Citrate

Contact Research Centre

Eosinophilic granulomatosis with polyangiitis

Not recruiting

Registered drug

Study on Mepolizumab and Drug Combination for Patients with Eosinophilic Granulomatosis with Polyangiitis

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Azathioprine

Contact Research Centre

Acute myeloid leukaemia

Not recruiting

Registered drugNo placebo

Study on Venetoclax, Azacitidine, and Donor Lymphocyte Infusion for Patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia Relapse After Transplantation

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Gastric cancer

Not recruiting

Registered drugNo placebo

Study on Pembrolizumab for Patients with Localized Non-Metastatic MSI/dMMR Tumors or EBV+ Gastric Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Acute myeloid leukaemia+1

Not recruiting

Registered drugNo placebo

Study of three different doses of busulfan with fludarabine and thymoglobuline in stem cell transplantation for patients with high-risk myeloid blood disorders

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Busulfan

Contact Research Centre

Critical illness

Not recruiting

Registered drug

Study on Hydrocortisone and Fludrocortisone for Adults with Critical Illness-Related Corticosteroid Insufficiency

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Tetracosactide

Contact Research Centre

Plasma cell leukaemia

Not recruiting

Registered drugNo placebo

Study on Daratumumab, Lenalidomide, and Dexamethasone for Patients with Primary Plasma Cell Leukemia

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Bortezomib

Contact Research Centre

Acute myeloid leukaemia+1

Not recruiting

Investigational

Study of Ivosidenib or Enasidenib with Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with IDH1 or IDH2 Mutation

Investigational

France

Participants:18–64 years · 65+ years
Substances:Enasidenib Mesilate

Contact Research Centre

Immune thrombocytopenia

Not recruiting

Registered drugNo placebo

Study comparing dexamethasone versus immunoglobulin plus prednisone for adults with immune thrombocytopenia (ITP) who have moderate to severe bleeding

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Dexamethasone

Contact Research Centre

Myelofibrosis+1

Not recruiting

Registered drugNo placebo

Study of Navtemadlin for Patients with Myelofibrosis Resistant to JAK Inhibitors

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Danazol

Contact Research Centre

Find therapies in clinical trials near you – page 30

454 trials match your criteria

Study on Early vs. Late Epoetin Alfa Treatment for Adults with Low-Risk MDS and Anemia Not Requiring Blood Transfusions

Study on Early vs. Late Epoetin Alfa Treatment for Adults with Low-Risk MDS and Anemia Not Requiring Blood Transfusions

Chronic myelomonocytic leukaemia

Study on the Safety and Effectiveness of Azacitidine and Venetoclax for Patients with Higher-Risk Chronic Myelomonocytic Leukemia (CMML)

Peripheral arterial occlusive disease

Study of sildenafil to improve walking distance in patients with peripheral arterial disease and intermittent claudication

Eosinophilic granulomatosis with polyangiitis

Study on Mepolizumab and Drug Combination for Patients with Eosinophilic Granulomatosis with Polyangiitis

Acute myeloid leukaemia

Study on Venetoclax, Azacitidine, and Donor Lymphocyte Infusion for Patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia Relapse After Transplantation

Gastric cancer

Study on Pembrolizumab for Patients with Localized Non-Metastatic MSI/dMMR Tumors or EBV+ Gastric Cancer

Acute myeloid leukaemia+1

Study of three different doses of busulfan with fludarabine and thymoglobuline in stem cell transplantation for patients with high-risk myeloid blood disorders

Critical illness

Study on Hydrocortisone and Fludrocortisone for Adults with Critical Illness-Related Corticosteroid Insufficiency

Plasma cell leukaemia

Study on Daratumumab, Lenalidomide, and Dexamethasone for Patients with Primary Plasma Cell Leukemia

Acute myeloid leukaemia+1

Study of Ivosidenib or Enasidenib with Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with IDH1 or IDH2 Mutation

Immune thrombocytopenia

Study comparing dexamethasone versus immunoglobulin plus prednisone for adults with immune thrombocytopenia (ITP) who have moderate to severe bleeding

Myelofibrosis+1

Study of Navtemadlin for Patients with Myelofibrosis Resistant to JAK Inhibitors

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.